SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

By afschroeder • October 30, 2026

Peluso MJ, Ryder D, Dalhuisen T, Chu DHT, Williams MC, Rodriguez AE, LaFranchi BH, Vinden J, Fehrman EA, Huang B, Hoh R, Asare KA, Bellon Pizarro K, Rahman MS, de Narvaez E, Painter MM, Wherry EJ, Swank ZN, Hansen LL, Walt DR, Fukazawa Y, Sekar A, Bellan SE, Tieu H, Asiago J, Bhuyan P, Venkayya R, Flavell RR, VanBrocklin H, Kelly JD, Hsue PY, Durstenfeld MS, Hunt PW, Calabrese L, Somsouk M, Martin JN, Glidden DV, Deitchman AN, Henrich TJ, Deeks SG. SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial. Nat Commun. 2026 Sep 30;17(1):11205. doi: 10.1038/s41467-026-77925-y. PMID: 42957665.

Tags: Cardiology/Epi, Publications

Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR

Pogosyan A, Liu Y, Patel JA, Mahmoudi M, Xu H, Finn JP, Nguyen KL. Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR. Curr[...]

A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention

Song MR, Ziaeian B. A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention. JACC Heart Fail. 2026 Oct 28:103489. doi: 10.1016/j.jchf.2026.103489. Epub[...]

Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study

Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung[...]